Banque Transatlantique’s AstraZeneca AZN Stock Holding History

Banque Transatlantique’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.1M	Buy	62,182 +61,981	+30,836%	+$12M	0.29%	46
2025 Q4	$37K	Hold	201	–	–	﹤0.01%	172
2025 Q3	$30.8K	Hold	201	–	–	﹤0.01%	185
2025 Q2	$28.2K	Hold	201	–	–	﹤0.01%	173
2025 Q1	$29.5K	Hold	201	–	–	﹤0.01%	162
2024 Q4	$26.2K	Buy	+201	New	+$28.1K	﹤0.01%	188

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Banque Transatlantique's AZN Position: Q1 2026 in Review

Banque Transatlantique increased its AstraZeneca (AZN) stake by 30,836% in Q1 2026, buying an estimated $12M and bringing the position to 62,182 shares worth $12.1M. The position accounts for 0.29% of the portfolio, ranked #46.

Banque Transatlantique first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Banque Transatlantique held 62,182 shares of AstraZeneca worth $12.1M as of Q1 2026.
Banque Transatlantique bought 61,981 AstraZeneca shares in Q1 2026, an estimated $12M.
AstraZeneca made up 0.29% of Banque Transatlantique's portfolio in Q1 2026, its #46 holding.
Banque Transatlantique first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.